Two gout experts debated whether first-line urate-lowering therapy should consist of a xanthine oxidase inhibitor or should ...
The presentation highlights XORTX recent pioneering discoveries in the field of Autosomal Dominant Polycystic Kidney Disease (“ADPKD”), and recent peer-reviewed, independent, published research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback